Financial Performance - The company's operating revenue for the first half of 2023 was ¥7,219,257,528.71, a decrease of 20.45% compared to ¥9,074,695,768.00 in the same period last year[13]. - The net profit attributable to shareholders for the first half of 2023 was ¥792,413,099.69, down 44.38% from ¥1,424,746,844.43 in the previous year[14]. - The basic earnings per share for the first half of 2023 were ¥0.2511, a decrease of 42.76% from ¥0.4387 in the same period last year[15]. - The weighted average return on net assets decreased to 2.44%, down 2.16 percentage points from 4.60% in the previous year[15]. - The decline in net profit and earnings per share was primarily due to a decrease in product sales and prices, leading to a drop in profit margins[16]. - Net profit attributable to shareholders after deducting non-recurring gains and losses was 812 million RMB, a decline of 29.89% year-on-year[22]. - The company achieved operating revenue of 7.219 billion RMB, a year-on-year decrease of 20.45%[22]. - The company reported a total comprehensive income of CNY 993,745,383.36, down 43.7% from CNY 1,765,219,558.78 in the same period of 2022[92]. Cash Flow and Assets - The net cash flow from operating activities significantly increased to ¥3,267,672,274.83, compared to ¥118,056,355.62 in the same period last year, marking a rise of 2,667.89%[14]. - Cash and cash equivalents increased by 82.11% to ¥12,519,498,710.70 from ¥6,874,503,308.48 year-on-year[27]. - The total assets at the end of the reporting period were ¥69,979,820,001.49, reflecting a 7.39% increase from ¥65,161,739,457.60 at the end of the previous year[14]. - The company reported a total cash balance of CNY 12,519,498,710.70 at the end of the period, up from CNY 6,874,503,308.48 at the beginning of the period, indicating a significant increase of approximately 82%[183]. Investments and R&D - The company is focusing on internal R&D and external acquisitions to enrich its product line and expand market share[21]. - Research and development expenses decreased by 25.20% to ¥277,601,822.05 from ¥371,119,787.32 year-on-year[24]. - The company is investing $30 million in research and development for new technologies aimed at enhancing product efficiency[174]. Environmental Management - The company is implementing a "zero emissions" management concept in its production processes[21]. - The company emphasizes safety in its chemical operations, implementing improvements based on the DuPont sustainable solutions to enhance safety management[37]. - The company has established a comprehensive environmental management system to monitor and control emissions across its operations[45]. - The company has committed to not engaging in competitive activities that conflict with its business operations, ensuring compliance from major shareholders[55]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 166,733[67]. - The top ten shareholders held a combined 37.32% of the company's shares, with the largest shareholder holding 11.98%[68]. - The company has no significant changes in share capital structure during the reporting period[66]. Risk Management - The company faces management risks due to the increasing number of subsidiaries, necessitating enhanced oversight and internal auditing to prevent mismanagement[38]. - The company is exposed to foreign exchange risks due to operations in multiple currencies, but currently employs natural hedging methods to manage this risk[38]. - The company has a structured approach to risk management, prioritizing safety and environmental considerations in its operations[37]. Legal and Compliance - The company has not reported any significant litigation or arbitration matters during the reporting period[57]. - The company and its subsidiaries are involved in a patent infringement lawsuit, with a claim for economic damages amounting to RMB 230 million, and a court ruling requiring compensation of RMB 14 million and additional costs totaling RMB 3.8 million[58]. Accounting Policies - The financial statements comply with the requirements of the enterprise accounting standards, accurately reflecting the company's financial position and operating results[120]. - The company applies specific accounting treatment for mergers and acquisitions, recognizing goodwill when the purchase cost exceeds the fair value of identifiable net assets acquired[124]. - The company recognizes revenue based on the progress of performance obligations, confirming income when control of goods or services is transferred to the customer[167].

证券代码：600352 证券简称：浙江龙盛 公告编号：2023-039 号 浙江龙盛集团股份有限公司 2023 年上半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 根据上海证券交易所《上市公司自律监管指引第 3 号——行业信息披露》的 要求，公司现将 2023 年上半年度主要经营数据披露如下： 注：上述产品销量包含了部分外购成品再销售的量。 二、主要产品和原材料的价格变动情况 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 2022年第二季度 2022年第三季度 2022年第四季度 2023年第一季度 2023年第二季度 主要产品销售价格波动走势图 分散染料 活性染料 德司达分散 德司达活性 德司达靛蓝 德司达助剂 间苯二胺 间苯二酚 单位：元/吨 （二）主要原料价格(不含增值税)波动情况 第 2 页 共 4 页 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2022年第二季度 20 ...

证券代码：600352 证券简称：浙江龙盛 公告编号：2023-041 号 2023年8月25日，公司已兑付2023年度第一期超短期融资券(科创票据)本息 合计人民币809,311,475.41元，由银行间市场清算所股份有限公司代理划付至债 券持有人。 特此公告。 浙江龙盛集团股份有限公司 董 事 会 二 0 二三年八月二十六日 浙江龙盛集团股份有限公司 2023 年度第一期超短期融资券(科创票据) 兑付完成公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 本公司于2023年3月27日在全国银行间债券市场公开发行2023年度第一期超 短期融资券(科创票据)（简称"23龙盛SCP001(科创票据)"，代码"012381234"）， 发行规模8亿元人民币，期限为150日，计息方式：零息利率，兑付日：2023年8 月25日，发行价格为100元/百元面值，票面利率为2.84%。具体内容详见2023年3 月29日披露的《关于2023年度第一期超短期融资券(科创票据)发行结果的公告》 （公告编号：2023-009号）。 ...

证券代码：600352 证券简称：浙江龙盛 公告编号：2023-040 号 浙江龙盛集团股份有限公司 关于举行 2023 年上半年度网上业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1、会议召开时间：2023 年 8 月 31 日下午 15:00—17:00 2、会议召开网址：公司网站（http://www.longsheng.com） 3、会议召开方式：网络平台在线交流 4、投资者可在 2023 年 8 月 31 日 15:00 前通过公司"互动平台"上先提出 所关注的问题，公司将在说明会上选择投资者普遍关注的问题进行回答。 一、说明会类型 公司已于 2023 年 8 月 26 日披露公司《2023 年半年度报告》（刊登在《上海 证券报》、《证券时报》和《证券日报》及上海证券交易所网站）。为便于广大投 资者更全面深入地了解公司生产经营、财务、战略、投资等方面情况，公司决定 通过网络远程的方式举行"2023 年上半年度网上业绩说明会"。 二、说明会召开的时间 会议召开时间：2023 年 8 ...

被担保人名称：公司全资子公司浙江鸿盛化工有限公司（以下简称"浙 江鸿盛"）、浙江安诺芳胺化学品有限公司（以下简称"浙江安诺"）和绍兴市上 虞金冠化工有限公司（以下简称"绍兴金冠"）。 本次担保金额及已实际为其提供的担保余额：公司本次为浙江鸿盛提供 最高额保证，其中在光大银行担保的主债权最高本金余额为人民币 2.5 亿元，在 工商银行担保的最高债权额为人民币 7 亿元；为浙江安诺提供最高额保证，担保 最高债权额为人民币 3.8 亿元；为绍兴金冠提供最高额保证，担保最高债权额为 人民币 4.3 亿元。截至 2023 年 8 月 10 日，公司实际为浙江鸿盛提供担保余额共 计人民币 23.37 亿元，为浙江安诺提供担保余额共计人民币 4.95 亿元，为绍兴 金冠提供担保余额共计人民币 5.61 亿元，上述担保均在股东大会核定的担保额 度范围内。 上述担保均无反担保。 公司不存在逾期担保的情况。 证券代码：600352 证券简称：浙江龙盛 公告编号：2023-037 号 浙江龙盛集团股份有限公司 关于为全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥3,748,527,750.79, representing a decrease of 16.80% compared to the same period last year[4] - The net profit attributable to shareholders was ¥343,678,131.76, down 26.81% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥226,692,945.76, a decline of 59.08% compared to the previous year[4] - The company's basic and diluted earnings per share were both ¥0.1089, reflecting a decrease of 24.53% year-on-year[4] - The weighted average return on equity was 1.06%, down by 0.48 percentage points compared to the previous year[4] - Net profit for Q1 2023 was CNY 384,266,803.05, a decline of 29.4% from CNY 544,334,763.28 in Q1 2022[16] - The comprehensive income for Q1 2023 was ¥268,109,395.58, compared to ¥159,144,734.23 in Q1 2022, showing an increase of 68.5%[23] Cash Flow - The net cash flow from operating activities increased significantly by 623.97%, amounting to ¥1,520,648,057.45[4] - In Q1 2023, the company reported a net cash flow from operating activities of CNY 1,520,648,057.45, a significant increase from CNY 210,044,046.67 in Q1 2022, representing a growth of approximately 624%[17] - Total cash inflow from operating activities reached CNY 6,249,345,145.32, compared to CNY 4,420,875,213.08 in the same period last year, marking an increase of about 41.3%[17] - The company’s cash inflow from investment activities was CNY 296,170,858.98, compared to CNY 233,092,376.34 in Q1 2022, showing an increase of about 27.0%[18] - The net cash flow from investment activities was ¥80,281,370.51, recovering from a negative cash flow of -¥511,435,126.43 in Q1 2022, showcasing improved investment returns[24] Assets and Liabilities - Total assets at the end of the reporting period were ¥68,110,636,144.73, an increase of 4.53% from the end of the previous year[5] - The total assets increased to CNY 68,110,636,144.73 in Q1 2023 from CNY 65,161,739,457.60 in Q1 2022, reflecting a growth of 4.5%[14] - The total liabilities increased to CNY 33,083,470,506.44 in Q1 2023 from CNY 30,403,629,011.67 in Q1 2022, representing an increase of 8.8%[14] - The total liabilities decreased to CNY 23,367,284,275.24 from CNY 24,201,065,124.80, showing a reduction of approximately 3%[13] - The total liabilities to equity ratio was approximately 4.07 in Q1 2023, compared to 3.75 in Q1 2022, indicating increased leverage[21] Equity and Investments - The equity attributable to shareholders increased slightly by 0.69% to ¥32,387,761,453.91 compared to the end of last year[5] - The total equity attributable to shareholders of the parent company rose to CNY 32,387,761,453.91 in Q1 2023, up from CNY 32,166,710,058.29 in Q1 2022, an increase of 0.7%[14] - The long-term equity investments were valued at CNY 2,016,979,516.62, down from CNY 2,141,125,749.13, representing a decline of approximately 6%[13] Expenses - Research and development expenses for Q1 2023 were CNY 146,724,345.21, a decrease of 15.2% from CNY 172,976,678.20 in Q1 2022[15] - Financial expenses increased to CNY 102,103,838.37 in Q1 2023, compared to CNY 76,639,521.37 in Q1 2022, marking an increase of 33.2%[15] - The financial expenses in Q1 2023 were ¥69,836,228.29, significantly higher than ¥28,118,661.58 in Q1 2022, indicating an increase of 148.5%[22] Inventory and Receivables - The company's inventory stood at CNY 28,617,753,736.10, slightly down from CNY 28,648,522,837.86, indicating a decrease of about 0.1%[12] - Accounts receivable increased to CNY 2,798,438,924.32 from CNY 2,271,965,047.68, reflecting a growth of approximately 23%[12]

Financial Performance - The company's operating revenue for 2022 was CNY 21,225,642,671.37, representing a 27.41% increase compared to CNY 16,659,819,623.52 in 2021[15]. - Net profit attributable to shareholders for 2022 was CNY 3,003,132,773.22, a decrease of 10.99% from CNY 3,373,965,680.06 in 2021[15]. - The net profit after deducting non-recurring gains and losses was CNY 2,758,641,690.12, which is a 16.59% increase from CNY 2,366,027,185.29 in 2021[15]. - The net cash flow from operating activities decreased by 79.58% to CNY 955,938,154.82 from CNY 4,681,061,864.70 in 2021[15]. - The company's total assets at the end of 2022 were CNY 65,161,739,457.60, a slight decrease of 0.86% from CNY 65,726,507,288.30 in 2021[15]. - Basic earnings per share for 2022 were CNY 0.9357, down 10.27% from CNY 1.0428 in 2021[16]. - The weighted average return on net assets for 2022 was 9.61%, a decrease of 2.03 percentage points from 11.64% in 2021[16]. - Total profit amounted to 3.998 billion yuan, a decrease of 7.00% year-on-year[28]. - Net profit attributable to shareholders was 3.003 billion yuan, down 10.99% year-on-year[28]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was 2.759 billion yuan, an increase of 16.59% year-on-year[28]. - Total revenue for 2022 is 22.002 billion CNY, an increase of 32.07% compared to the previous year[126]. - Total profit for 2022 is 5.31 billion CNY, reflecting a growth of 23.51% year-over-year[126]. - Net profit attributable to shareholders is 4.25 billion CNY, up by 25.96% from the previous year[126]. Dividend and Profit Distribution - The company plans to distribute a cash dividend of 2.50 CNY per 10 shares, totaling an undistributed profit of 1,503,624,615.60 CNY as of December 31, 2022[3]. - The cumulative undistributed profits will be carried forward to the next fiscal year, with no capital reserve fund to be converted into share capital[3]. - The company declared a cash dividend of 2.50 RMB per 10 shares, totaling 788,932,962.75 RMB, which represents 26.27% of the net profit attributable to ordinary shareholders in the consolidated financial statements[133]. - The total amount of cash dividends, including share repurchases, reached 1,774,895,091.18 RMB, accounting for 59.10% of the net profit attributable to ordinary shareholders[133]. Audit and Compliance - The company has received a standard unqualified audit report from Tianjian Accounting Firm[2]. - The board of directors and supervisory board members have all attended the board meeting, ensuring the integrity of the annual report[2]. - The company has confirmed that all directors can guarantee the authenticity, accuracy, and completeness of the annual report[4]. - The company has not violated any decision-making procedures regarding external guarantees[4]. - The company reported no significant risks that could materially affect its production and operations during the reporting period[5]. - The company has confirmed that there are no non-operating fund occupations by controlling shareholders or related parties[4]. - The company has established a comprehensive internal control system, which was evaluated in the 2022 annual internal control evaluation report[96]. - The company received a standard unqualified opinion on its internal control audit for the fiscal year 2022, confirming effective financial reporting controls[141]. Research and Development - The company holds nearly 1,900 domestic and international patents, supporting its strong R&D capabilities[26]. - The company aims to enhance its product line through continuous internal R&D and external acquisitions[26]. - Research and development expenses rose by 8.72% to ¥709,411,015.68, attributed to increased investment in materials and energy for R&D[29]. - The number of R&D personnel is 546, making up 8.25% of the total workforce[45]. - Zhejiang Longsheng is investing 200 million RMB in R&D for innovative dyeing technologies over the next two years[113]. Environmental Responsibility - The company has invested 57,078.48 million RMB in environmental protection during the reporting period[142]. - The company reported a total wastewater discharge of 2,776,299 tons during the reporting period, with COD concentration ranging from 0.84 to 94.48 mg/L, totaling 203.034 tons of COD discharged[144]. - The company generated 66,675.04 tons of general solid waste and 24,096.42 tons of hazardous solid waste, all disposed of legally and compliantly[144]. - The company’s wastewater discharge met the annual requirements of 4,576,160 tons and COD and ammonia nitrogen limits of 338.093 tons and 51.147 tons respectively[144]. - The company has implemented measures to ensure that all emissions from its facilities are treated to meet environmental standards before being released into the atmosphere[143]. - The company has established various pollution control facilities, including a 15,000 tons/day wastewater treatment facility and a 3,000 tons/day wastewater treatment facility, ensuring zero accidents in environmental governance[145]. - The company has published its 2022 Corporate Social Responsibility Report, detailing its efforts in sustainability and community engagement[150]. Market Strategy and Expansion - The company plans to focus on expanding its market presence in both domestic and international regions, including key areas in Germany, the USA, and Brazil[33]. - The company aims to achieve a green and low-carbon transformation in the chemical industry during the 14th Five-Year Plan period, in line with national carbon peak goals[54]. - The company is focusing on new product development and technological advancements to drive future growth[85]. - The company plans to expand its market presence in Southeast Asia, targeting a 30% increase in market share by 2025[113]. - The company is committed to enhancing its core competitiveness through innovation-driven development strategies and sustainable practices[54]. Legal and Governance Issues - The company is currently involved in a significant lawsuit regarding patent infringement, with a claim for economic damages of RMB 230 million[157]. - The court ruled that the company must pay RMB 14 million in damages and additional costs related to the patent infringement case[157]. - The company has faced multiple legal challenges, including an ongoing appeal regarding the valuation of the aforementioned stake[158]. - The company has established a legal framework to ensure the independence of its operations from its controlling shareholders[98]. - The company has established specialized committees, including the audit committee and the strategic committee, to enhance governance and oversight[121]. Shareholder Information - The total number of shares held by the chairman and general manager remained unchanged at 346,321,538 shares, with a pre-tax remuneration of 412.43 million yuan[104]. - The total number of shares held by the vice general manager and board secretary also remained unchanged at 4,891,467 shares, with a pre-tax remuneration of 123.31 million yuan[104]. - The total number of shares held by the financial director remained unchanged at 0 shares, with a pre-tax remuneration of 131.31 million yuan[104]. - The total number of shares held by the deputy general manager remained unchanged at 3,306,329 shares, with a pre-tax remuneration of 160.76 million yuan[104]. - The total number of shares held by the independent directors remained unchanged at 0 shares, with a pre-tax remuneration of 12.00 million yuan each[104]. - The total number of shares held by the supervisory board chairman remained unchanged at 0 shares, with a pre-tax remuneration of 29.51 million yuan[104]. - The total number of shares held by the employee representative supervisor remained unchanged at 0 shares, with a pre-tax remuneration of 3.43 million yuan[104]. - The total number of shares held by the company’s directors and supervisors at the end of the reporting period was 392,332,236 shares, with a total pre-tax remuneration of 1,435.70 million yuan[104]. Debt and Financing - The company has issued a total of 20 billion RMB in corporate bonds, with interest rates ranging from 2.90% to 3.95%[186]. - The company completed interest payments for its bonds on various dates in 2022, including the first phase on March 3, 2022, and the second phase on April 21, 2022[188]. - The company has issued multiple short-term financing bonds in 2022, with amounts ranging from RMB 2.5 billion to RMB 5 billion, all of which have been repaid on schedule[194]. - The company has issued a total of RMB 8.00 billion in the first phase of 2023 short-term financing bonds, with a repayment date set for August 25, 2023[193]. - The company has no overdue bonds reported, indicating a stable debt repayment status[193].

证券代码：600352 证券简称：浙江龙盛 公告编号：2023-020 号 浙江龙盛集团股份有限公司 关于在网上举办 2022 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 1、会议召开时间：2023 年 4 月 21 日下午 15:00—17:00 2、会议召开网址：公司网站（https://www.longsheng.com） 3、会议召开方式：网络平台在线交流 4、投资者可在 2023 年 4 月 21 日 15:00 前通过本公告后附的电话 （0575-82048616）、传真（0575-82041589）或者电子邮件（stock@lonsen.com） 方式联系公司，提出所关注的问题，也可在公司"互动平台"上先提出所关注的 问题，公司将在说明会上选择投资者普遍关注的问题进行回答。 一、说明会类型 公司已于 2023 年 4 月 15 日披露《2022 年年度报告》（刊登在《上海证券报》、 《证券时报》和《证券日报》及上海证券交易所网站）。根据《上海证券交易所 上市公司自律 ...

Financial Performance - The company's operating revenue for Q3 2022 was ¥4,347,560,357.18, representing a year-over-year increase of 4.68%[4] - The net profit attributable to shareholders for Q3 2022 was ¥300,464,644.24, a decrease of 37.65% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥497,974,268.18, down 11.70% year-over-year[4] - Basic earnings per share for Q3 2022 were ¥0.0960, a decrease of 34.38% from the same period last year[6] - Total operating revenue for the first three quarters of 2022 reached ¥13,422,256,125.18, an increase of 6.8% compared to ¥12,566,191,878.76 in the same period of 2021[18] - Net profit for the first three quarters of 2022 was ¥1,958,350,533.04, a decrease of 39.4% from ¥3,233,767,062.17 in 2021[19] - The company's earnings per share for the first three quarters was ¥0.5347, down from ¥0.9308 in the same period of 2021[19] - The comprehensive income for the period was reported at ¥576.03 million, down from ¥946.35 million, a decrease of about 39.1%[26] Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥1,231,201,344.78, reflecting a significant decline of 68.13% compared to the previous year[4] - In the first three quarters of 2022, the net cash flow from operating activities was ¥882,867,808.27, a decrease of 55.2% compared to ¥1,968,735,460.06 in the same period of 2021[27] - Total cash inflow from operating activities was ¥8,346,005,966.62, down 63.4% from ¥22,768,873,189.71 year-on-year[27] - The cash flow from sales of goods and services was ¥1,676,383,419.80, a decline from ¥1,993,665,517.14 in the previous year[27] - The cash inflow from financing activities totaled ¥9,030,000,000.00, a decrease of 22.0% compared to ¥11,583,000,000.00 in the same period last year[27] - The net cash flow from financing activities was ¥568,119,667.32, down 77.0% from ¥2,466,400,155.29 in 2021[27] Assets and Liabilities - The total assets at the end of the reporting period were ¥69,910,138,771.75, an increase of 6.37% from the end of the previous year[6] - The total current liabilities increased significantly to CNY 30.97 billion from CNY 23.12 billion, which is an increase of approximately 33.5%[16] - The company's total liabilities increased to ¥36,426,282,739.74, compared to ¥32,768,896,745.96 in the previous year, reflecting a growth of 11.1%[17] - The total equity attributable to shareholders of the parent company rose to ¥31,178,896,349.16, up from ¥30,363,837,288.07, marking an increase of 2.7%[17] - The total equity decreased to ¥6.68 billion from ¥7.81 billion, reflecting a decline of about 14.4%[24] Research and Development - The company has ongoing research and development efforts focused on new products and technologies, although specific figures were not disclosed in the report[12] - Research and development expenses for the first three quarters were ¥544,269,033.83, slightly higher than ¥520,048,088.37 in the same period last year[18] - Research and development expenses remained stable at ¥66.42 million, compared to ¥66.05 million in the previous year, indicating a commitment to innovation[25] Market Outlook and Strategy - Future outlook includes plans for market expansion and potential mergers and acquisitions to enhance growth opportunities[12] - The company has a strong shareholder base, with the top two shareholders holding a combined 22.63% of the shares, indicating a stable ownership structure[12] Operational Challenges - The company reported a significant decline in net profit for the year-to-date period, down 42.61% due to decreased investment fair value and equity investment income[9] - The company experienced a decrease in gross profit margin for dye and intermediate businesses due to rising raw material costs[9] - Non-recurring losses for the reporting period included a loss of ¥365,381,828.51 related to ineffective hedging[7]

Financial Performance - The company's operating revenue for the first half of 2022 was CNY 9,074,695,768, representing a 7.87% increase compared to CNY 8,412,907,423 in the same period last year[14]. - The net profit attributable to shareholders of the listed company decreased by 43.56% to CNY 1,424,746,844.43 from CNY 2,524,206,667.89 in the previous year[14]. - The net cash flow from operating activities dropped significantly by 96.60% to CNY 118,056,355.62, compared to CNY 3,471,409,047.37 in the same period last year[14]. - Basic earnings per share decreased by 44.08% to CNY 0.4387 from CNY 0.7845 in the same period last year[16]. - The weighted average return on net assets fell by 4.17 percentage points to 4.60% from 8.77% in the previous year[16]. - Operating profit decreased by 38.60% to 192,283,010.00 RMB, while net profit attributable to shareholders fell by 43.56% to 142,474,680.00 RMB[25]. - The net profit attributable to shareholders decreased due to rising raw material costs and declining product prices, resulting in reduced sales profits[17]. - The net cash flow from operating activities declined primarily due to increased payments for raw materials compared to the same period last year[17]. Assets and Liabilities - The total assets increased by 6.51% to CNY 70,005,786,013.71 from CNY 65,726,507,288.30 at the end of the previous year[15]. - The total liabilities increased to ¥36,705,348,670.73 from ¥32,768,896,745.96, which is an increase of around 12.0%[82]. - The total equity attributable to shareholders increased to ¥30,650,109,406.49 from ¥30,363,837,288.07, showing a growth of approximately 0.9%[83]. - The debt-to-asset ratio increased by 2.58 percentage points to 52.43% compared to the end of the previous year[79]. - The total liabilities to equity ratio increased to approximately 1.21 from 0.99, indicating a higher leverage position[82]. Cash Flow - The company's cash flow from operating activities saw a significant decline of 96.60%, amounting to 118,056,355.62 RMB[25]. - The company reported a total cash inflow from operating activities of CNY 8,824,963,573.22, down 22.2% from CNY 11,334,305,265.74 in the first half of 2021[89]. - The cash inflow from financing activities totaled CNY 8,826,587,871.76, down from CNY 11,140,630,273.45 in the first half of 2021[89]. - The net cash flow from financing activities was CNY 527,157,174.32, down from CNY 2,324,304,969.22 in the first half of 2021, representing a decline of approximately 77%[91]. Investments and Subsidiaries - The company holds nearly 1,900 patents, supporting its strong R&D capabilities for high-end market product development[23]. - The intermediate products business remains a major profit source, with global dye sales reaching 124,300 tons and intermediate sales at 42,500 tons[24]. - The company is focusing on expanding its market presence through strategic investments in various sectors, including chemicals and real estate[35]. - Zhejiang Longsheng reported a total investment of CNY 5,114,108,662.22 with a net profit of CNY 71,884,058.61 for the reporting period[34]. - The company has significant investments in various entities, including CNY 303 million in Hangzhou Hanzhi Investment Partnership and CNY 500 million in Sanya Changze Hongji Venture Capital[32]. Environmental and Safety Initiatives - The company has implemented a "zero emissions" management concept and is actively engaged in pollution reduction and carbon reduction initiatives[23]. - The company operates 10 key pollutant discharge units, with a total of 143 emission outlets for major pollutants including sulfur dioxide, nitrogen oxides, and particulate matter[44]. - The company has established a wastewater treatment facility with a capacity of 15,000 tons/day and a 3,000 tons/day facility for treating wastewater[46]. - The company has upgraded its pollution control systems to achieve zero accidents in environmental protection and has implemented intelligent upgrades for all waste gas treatment devices[46]. Legal and Compliance - The company has not reported any significant litigation or arbitration matters during the reporting period[56]. - The company and its subsidiaries are involved in ongoing legal disputes, including a patent infringement case where the court ordered compensation of RMB 14 million and additional costs totaling RMB 930,444[57]. - The company has committed to not engaging in competitive activities that conflict with its business operations, ensuring compliance with its commitments[54]. Shareholder Information - The total number of ordinary shareholders as of the end of the reporting period is 190,113[67]. - The top ten shareholders hold a total of 1,042,000,000 shares, representing 31.73% of the total shares[68]. - The largest shareholder, Ruan Shuilong, holds 389,653,992 shares, accounting for 11.98% of the total shares[68]. - The company plans to repurchase shares with a total fund not less than 500 million RMB and not exceeding 1 billion RMB, with the repurchase period from April 26, 2022, to October 25, 2022[65]. Accounting Policies - The financial statements comply with the requirements of the enterprise accounting standards, accurately reflecting the company's financial position and operating results[107]. - The company recognizes financial assets and liabilities at fair value upon initial recognition, with subsequent measurement based on their classification[116]. - The company assesses credit risk for financial instruments at each balance sheet date, determining if there has been a significant increase in credit risk since initial recognition[118]. - The company recognizes deferred tax assets and liabilities based on the difference between the book value of assets and liabilities and their tax bases, calculated at applicable tax rates[155].